Glucocorticoids for decompensated heart failure

  title={Glucocorticoids for decompensated heart failure},
  author={Na Wang and Mu Qiao and Hong Meng and Chao Liu},
  journal={Cochrane Database of Systematic Reviews},
  • Na WangMu Qiao Chao Liu
  • Published 17 September 2015
  • Medicine
  • Cochrane Database of Systematic Reviews
Reason for Withdrawal The Cochrane Heart Group withdrew this protocol as the current author team are unable to progress to the final review stage. To view the published versions of this article, please click the 'Other versions' tab. 

Prednisone in Uric Acid Lowering in Symptomatic Heart Failure Patients with Hyperuricemia — The PUSH-PATH3 Study

Prednisone can be used safely in symptomatic HF patients with hyperuricemia and is associated with a remarkable increase in urine output, improvement in renal function, and improvement in clinical status.

Effect of Corticosteroid on Renal Water and Sodium Excretion in Symptomatic Heart Failure: Prednisone for Renal Function Improvement Evaluation Study

Only low-dose prednisone significantly enhanced urine output and renal sodium excretion, and high-dose Prednisone induced a more potent natriuresis and diuresis induced byprednisone.

Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats: Erratum

  • Medicine, Biology
    Journal of Cardiovascular Pharmacology
  • 2015
The type I and type II 11betahydroxysteroid dehydrogenase enzymes and the effect of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insuffential failure are studied.



Effect of nesiritide in patients with acute decompensated heart failure.

Nesiritide was not associated with an increase or a decrease in the rate of death and rehospitalization and had a small, nonsignificant effect on dyspnea when used in combination with other therapies.

Diuretics in cardiac edema--1969.

  • H. Shanoff
  • Medicine
    Canadian Medical Association journal
  • 1969
The appreciation of a few simplified facts about cardiac edema and renal reabsorption of sodium makes the clinical pharmacology of the diuretics much easier to understand, remember and apply.

Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations

More information obtained in large-scale studies that are appropriately designed to evaluate the effect of variable doses of nitroglycerin on short- and long-term cardiovascular outcome, with and without interventions shown to prevent nitrate tolerance, is needed before intravenous nitrogoglyin can be recommended as a standard therapy for ADHF.

Levosimendan na insuficiência cardíaca descompensada: revisão sistemática e metanálise

The evidence available so far has shown no benefit in terms of mortality in association with the use of levosimendan, which only showed a small benefit in the time of hospitalization.

Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials

This meta-analysis showed that dobutamine is not associated with improved mortality in patients with heart failure, and there is a suggestion of increased mortality associated with its use, although this did not reach the conventional level of statistical significance.

Ultrafiltration in decompensated heart failure with cardiorenal syndrome.

In a randomized trial involving patients hospitalized for acute decompensated heart failure, worsened renal function, and persistent congestion, the use of a stepped pharmacologic-therapy algorithm was superior to a strategy of ultrafiltration for the preservation of renal function at 96 hours, with a similar amount of weight loss with the two approaches.